Skip to main navigation Skip to search Skip to main content

Problematic End Points in a Trial of Topical Fluorouracil, 5%, for Chemoprevention of Keratinocyte Carcinoma-Reply

  • Veterans Affairs Keratinocyte Carcinoma Chemoprevention Trial (VAKCC) Group
  • , Veterans Affairs Keratinocyte Carcinoma Chemoprevention Trial (VAKCC) Group

Research output: Contribution to journalLetterpeer-review

Original languageEnglish
Pages (from-to)851-852
Number of pages2
JournalJAMA Dermatology
Volume154
Issue number7
DOIs
StatePublished - Jul 2018

ASJC Scopus Subject Areas

  • Dermatology

Keywords

  • Carcinoma, Squamous Cell
  • Chemoprevention
  • Humans
  • Keratinocytes
  • Fluorouracil

Cite this